-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hot+l9+L//xFr2jMGw9Z2VapD8liXFuyi5GVeIbQkpvmGQUbIFS3n7BBY7AajykS Y8s47vkyspA6/JAnTJsZRw== 0001191076-08-000002.txt : 20080229 0001191076-08-000002.hdr.sgml : 20080229 20080229185201 ACCESSION NUMBER: 0001191076-08-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080228 FILED AS OF DATE: 20080229 DATE AS OF CHANGE: 20080229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOBDEN ADRIAN N CENTRAL INDEX KEY: 0001191076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 08657505 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2008-02-28 0 0000899923 MYRIAD GENETICS INC MYGN 0001191076 HOBDEN ADRIAN N 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Pres. Myriad Pharmaceuticals Incentive Stock Option (right to buy) 37.56 2008-02-28 4 A 0 2662 0 A 2018-02-28 Common Stock 2662 2662 D Non-Qualified Stock Option (right to buy) 37.56 2008-02-28 4 A 0 52338 0 A 2018-02-28 Common Stock 52338 52338 D The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. By: Richard Marsh For: Adrian N. Hobden 2008-02-29 -----END PRIVACY-ENHANCED MESSAGE-----